157 related articles for article (PubMed ID: 26885500)
1. Tanshinone IIA Attenuates Renal Fibrosis after Acute Kidney Injury in a Mouse Model through Inhibition of Fibrocytes Recruitment.
Jiang C; Shao Q; Jin B; Gong R; Zhang M; Xu B
Biomed Res Int; 2015; 2015():867140. PubMed ID: 26885500
[TBL] [Abstract][Full Text] [Related]
2. Rescue therapy with Tanshinone IIA hinders transition of acute kidney injury to chronic kidney disease via targeting GSK3β.
Jiang C; Zhu W; Yan X; Shao Q; Xu B; Zhang M; Gong R
Sci Rep; 2016 Nov; 6():36698. PubMed ID: 27857162
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA Protects Against Folic Acid-Induced Acute Kidney Injury.
Jiang C; Zhu W; Shao Q; Yan X; Jin B; Zhang M; Xu B
Am J Chin Med; 2016; 44(4):737-53. PubMed ID: 27222061
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
Wang DT; Huang RH; Cheng X; Zhang ZH; Yang YJ; Lin X
Int Immunopharmacol; 2015 May; 26(1):4-12. PubMed ID: 25744602
[TBL] [Abstract][Full Text] [Related]
5. Effects of tanshinone IIA on the regulation of renal proximal tubular fibrosis.
Cao L; Huang B; Fu X; Yang J; Lin Y; Lin F
Mol Med Rep; 2017 Jun; 15(6):4247-4252. PubMed ID: 28440499
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen peroxide-mediated oxidative stress and collagen synthesis in cardiac fibroblasts: blockade by tanshinone IIA.
Wang P; Zhou S; Xu L; Lu Y; Yuan X; Zhang H; Li R; Fang J; Liu P
J Ethnopharmacol; 2013 Jan; 145(1):152-61. PubMed ID: 23164764
[TBL] [Abstract][Full Text] [Related]
7. Effects of tanshinone IIA on fibrosis in a rat model of cirrhosis through heme oxygenase-1, inflammation, oxidative stress and apoptosis.
Shu M; Hu XR; Hung ZA; Huang DD; Zhang S
Mol Med Rep; 2016 Apr; 13(4):3036-42. PubMed ID: 26936326
[TBL] [Abstract][Full Text] [Related]
8. Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression.
Tampe B; Steinle U; Tampe D; Carstens JL; Korsten P; Zeisberg EM; Müller GA; Kalluri R; Zeisberg M
Kidney Int; 2017 Jan; 91(1):157-176. PubMed ID: 27692563
[TBL] [Abstract][Full Text] [Related]
9. Genetic and pharmacological inhibition of fatty acid-binding protein 4 alleviated inflammation and early fibrosis after toxin induced kidney injury.
Li L; Tao S; Guo F; Liu J; Huang R; Tan Z; Zeng X; Ma L; Fu P
Int Immunopharmacol; 2021 Jul; 96():107760. PubMed ID: 33991998
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA prevents uric acid nephropathy in rats through NF-κB inhibition.
Wu X; Liu L; Xie H; Liao J; Zhou X; Wan J; Yu K; Li J; Zhang Y
Planta Med; 2012 Jun; 78(9):866-73. PubMed ID: 22588836
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson's disease.
Ren B; Zhang YX; Zhou HX; Sun FW; Zhang ZF; Wei Z; Zhang CY; Si DW
J Neurol Sci; 2015 Jan; 348(1-2):142-52. PubMed ID: 25491263
[TBL] [Abstract][Full Text] [Related]
12. Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition.
Katagiri D; Hamasaki Y; Doi K; Negishi K; Sugaya T; Nangaku M; Noiri E
Kidney Int; 2016 Feb; 89(2):374-85. PubMed ID: 26535996
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA Attenuates H₂O₂ -induced injury in human umbilical vein endothelial cells.
Chan P; Chen YC; Lin LJ; Cheng TH; Anzai K; Chen YH; Liu ZM; Lin JG; Hong HJ
Am J Chin Med; 2012; 40(6):1307-19. PubMed ID: 23227799
[TBL] [Abstract][Full Text] [Related]
15. Janus kinase/signal transducer and activator of transcription inhibitors enhance the protective effect mediated by tanshinone IIA from hypoxic/ischemic injury in cardiac myocytes.
Zhang MQ; Tu JF; Chen H; Shen Y; Pang LX; Yang XH; Sun RH; Zheng YL
Mol Med Rep; 2015 Apr; 11(4):3115-21. PubMed ID: 25502794
[TBL] [Abstract][Full Text] [Related]
16. MRL/MpJ mice show unique pathological features after experimental kidney injury.
Shiozuru D; Ichii O; Kimura J; Nakamura T; Elewa YH; Otsuka-Kanazawa S; Kon Y
Histol Histopathol; 2016 Feb; 31(2):189-204. PubMed ID: 26345626
[TBL] [Abstract][Full Text] [Related]
17. Protection of Tanshinone IIA to human peritoneal mesothelial cells (HPMC) through delaying cellular senescence induced by high glucose.
Cao D; Zhang M; Jiang C; Xue L; Sun C
Ren Fail; 2012; 34(1):88-94. PubMed ID: 22032700
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Reticulon-1A-Mediated Endoplasmic Reticulum Stress in Early AKI Attenuates Renal Fibrosis Development.
Fan Y; Xiao W; Lee K; Salem F; Wen J; He L; Zhang J; Fei Y; Cheng D; Bao H; Liu Y; Lin F; Jiang G; Guo Z; Wang N; He JC
J Am Soc Nephrol; 2017 Jul; 28(7):2007-2021. PubMed ID: 28137829
[TBL] [Abstract][Full Text] [Related]
19. Short-term dexamethasone treatment transiently, but not permanently, attenuates fibrosis after acute-to-chronic kidney injury.
Moonen L; Geryl H; D'Haese PC; Vervaet BA
BMC Nephrol; 2018 Dec; 19(1):343. PubMed ID: 30509215
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone I protects mice from aristolochic acid I-induced kidney injury by induction of CYP1A.
Feng C; Xie X; Wu M; Li C; Gao M; Liu M; Qi X; Ren J
Environ Toxicol Pharmacol; 2013 Nov; 36(3):850-7. PubMed ID: 23981375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
